1、 Price trend:

According to the bulk list data of business society, the domestic market of PA6 operated smoothly in the first week of August, and the spot price was stable and small. As of August 9, the mainstream offer price of 2.75-2.85 of China viscosity by the sample enterprises was about 15366.67 yuan / ton, flat compared with the average price at the beginning of the month, with a year-on-year increase of 42.72%.

2、 Analysis of influencing factors:

In terms of upstream caprolactam, the current domestic market undertook that the industry load decreased at the end of last month, and the supply side was in short supply, which benefited the spot price. At the same time, the impact of the decline of raw material pure benzene is also gradually expanding. In August, the global spread of the mutant virus weighed on international oil prices, compounded by the blocked shipment of enterprises and insufficient downstream demand, and pure benzene fell significantly at the beginning of the month. Caprolactam was forced to follow the decline of raw materials, but the price range was still high, the demand side followed up carefully, and the spot trading on the floor was light.

The upstream caprolactam price fluctuated and fell at the beginning of the month. Although the cost side support of PA6 was weakened, it still remained in the high range. The caprolactam on the disk had great pressure on the cost of PA6, the profitability of the polymerization plant was poor, and the enterprise load was suppressed to a certain extent. Recently, the overall operating rate of domestic PA6 polymerization plant is about 60%, which has little change from the previous period. In terms of market demand, the demand for goods continues, and the consumption of terminal enterprises has not yet come out of the off-season market. The actual trading is mostly for manufacturers to complete early orders, and merchants try to make a firm offer. The market lacks kinetic energy and there is a heavy wait-and-see atmosphere on the floor.

3、 Future forecast:

Business analysts believe that in early August, although the upstream support for the cost side of PA6 weakened, the price of caprolactam was high and the cost pressure of PA6 was high. At the same time, the domestic slice inventory increased at the end of last month. End users follow up slowly and have a strong wait-and-see mentality. The atmosphere on the floor is weak and the long and short are tangled. It is expected that the spot price of PA6 may be deadlocked in the short term.